IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
13F holders, Q3 2022
Institutional positions in IMMUTEP Ltd as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q2 2022
- Shares held
- 5.33M
- −210.0K (−3.8%) vs. Q2 2022
- Total value
- $8.31M
- −$2.93M (−26.1%) vs. Q2 2022
- New holders
- 3
- 5 more added
- Sold out
- 4
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $692.0K |
| Q1 2026 | 26 | $916.3K |
| Q4 2025 | 25 | $5.68M |
| Q3 2025 | 32 | $3.68M |
| Q2 2025 | 24 | $2.75M |
| Q1 2025 | 23 | $2.95M |
| Q4 2024 | 26 | $4.22M |
| Q3 2024 | 23 | $4.26M |
| Q2 2024 | 28 | $4.84M |
| Q1 2024 | 23 | $5.40M |
| Q4 2023 | 23 | $4.90M |
| Q3 2023 | 21 | $3.68M |
| Q2 2023 | 21 | $3.41M |
| Q1 2023 | 19 | $4.95M |
| Q4 2022 | 25 | $7.25M |
| Q3 2022 | 21 | $8.31M |
| Q2 2022 | 22 | $11.2M |
| Q1 2022 | 23 | $14.4M |
| Q4 2021 | 25 | $17.5M |
| Q3 2021 | 28 | $30.9M |
| Q2 2021 | 28 | $32.9M |
| Q1 2021 | 13 | $14.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding IMMUTEP Ltd; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Oracle Investment Management Inc | 1,557,325 | $2.43M | 1.39% | 00.0% | Unchanged |
| Millennium Management LLC | 1,068,467 | $1.67M | 0.00% | −47,961−4.3% | Reduced |
| Artal Group S.A. | 1,000,000 | $1.56M | 0.08% | 00.0% | Unchanged |
| Morgan Stanley | 723,470 | $1.13M | 0.00% | −37,544−4.9% | Reduced |
| BlackRock Inc. | 517,096 | $807.0K | 0.00% | −15,656−2.9% | Reduced |
| Susquehanna International Group, LLP | 144,874 | $226.0K | 0.00% | +3,582+2.5% | Added |
| Dimensional Fund Advisors LP | 68,386 | $106.0K | 0.00% | +10,551+18.2% | Added |
| Envestnet Asset Management Inc | 65,834 | $103.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 35,000 | $55.0K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 35,173 | $55.0K | 0.00% | +35,173 | New |
| Citadel Advisors LLC | 29,463 | $46.0K | 0.00% | +8,452+40.2% | Added |
| Geode Capital Management, LLC | 18,722 | $29.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,201 | $24.0K | 0.00% | +5,488+56.5% | Added |
| Integrated Advisors Network LLC | 13,000 | $20.0K | 0.00% | +13,000 | New |
| UBS Group AG | 10,585 | $17.0K | 0.00% | +10,585 | New |
| Simplex Trading, LLC | 10,878 | $16.0K | 0.00% | −13,511−55.4% | Reduced |
| Bank of America Corp | 10,394 | $16.0K | 0.00% | −2,383−18.7% | Reduced |
| Citigroup Inc | 3,995 | $6.00K | 0.00% | +3,936+6,671.2% | Added |
| Group One Trading, L.P. | 1,080 | $2.00K | 0.00% | −5,367−83.2% | Reduced |
| Pittenger & Anderson Inc | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Trellus Management Company, LLC | 0 | $0 | 0.00% | −100,950−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −55,053−100.0% | Sold out |
| Saturna Capital CORP | 0 | $0 | 0.00% | −20,500−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,860−100.0% | Sold out |